Larvol Delta - TEJAS2-A-Study-Evaluating-the-Efficacy-Safety-Pharmacokinetics-and-Pharmacodynamics-of-AUR-109-in-Patients-With-Colorectal-Ovarian-and-Renal-Cancers

AUR-109 - Orion Corp, Dr. Reddy’s

http://clinicaltrials.gov/ct2/show/NCT06760702

Apr 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next